首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   165篇
  免费   5篇
林业   15篇
农学   3篇
  28篇
综合类   42篇
农作物   1篇
水产渔业   4篇
畜牧兽医   71篇
园艺   1篇
植物保护   5篇
  2021年   1篇
  2020年   1篇
  2019年   3篇
  2018年   2篇
  2017年   2篇
  2016年   3篇
  2014年   4篇
  2013年   10篇
  2012年   8篇
  2011年   6篇
  2010年   6篇
  2009年   5篇
  2008年   5篇
  2007年   7篇
  2006年   9篇
  2005年   10篇
  2004年   15篇
  2003年   8篇
  2002年   3篇
  2001年   3篇
  2000年   4篇
  1999年   2篇
  1998年   6篇
  1997年   1篇
  1996年   1篇
  1993年   3篇
  1992年   2篇
  1991年   4篇
  1990年   1篇
  1989年   3篇
  1988年   3篇
  1987年   1篇
  1985年   2篇
  1984年   7篇
  1983年   1篇
  1981年   1篇
  1980年   1篇
  1978年   1篇
  1975年   1篇
  1974年   1篇
  1973年   1篇
  1972年   2篇
  1971年   4篇
  1968年   2篇
  1966年   4篇
排序方式: 共有170条查询结果,搜索用时 31 毫秒
61.
Common seals Phoca vitulina vitulina Linnaeus 1758 were surveyed throughout Ireland during the 1978 breeding season. Compared with the abundance of the species in Great Britain, the Irish stock is small. The results are discussed in relation to the activities of man, particularly bounty hunting to protect fisheries, and the availability of suitable breeding localities. Problems relating to stock management, not least of which is that the species is subject to legislation in the south but not in the north, are discussed.  相似文献   
62.
63.
Exencephalia has been reported in irradiated CFI mice but there are no reports of its occurrence in untreated mice of this strain. In the course of establishing disease-free breeding colonies from CFI female mice delivered of their offspring by cesarean section, exencephalia was seen frequently. During a 2-week period, 90 litters were delivered; 11 contained exencephalic fetuses, at the rate of one per litter (11 of 90 litters, 12.2 percent; 11 of 1056 fetuses, 1.04 percent). The prevalence of this anomaly in untreated mice of this strain could contribute to overestimates of the effectiveness of low doses of radiation.  相似文献   
64.
65.
66.
67.
OBJECTIVES: To evaluate use of an ameroid ring constrictor (ARC) for treatment for single extrahepatic portosystemic shunts (PSSs) and identify factors associated with postoperative death, continued portosystemic shunting, and long-term outcome in dogs. DESIGN: Retrospective study. ANIMALS: 168 dogs with a single extrahepatic PSS. PROCEDURE: Medical records of dogs that had a single extrahepatic PSS and were treated with an ARC were reviewed. Signalment, history, clinical signs, results of preoperative blood analyses and portal pressure measurements, PSS location, ARC size, postoperative complications, and postoperative scintigraphy results were recorded. Owners were interviewed 6 months to 6 years after surgery. Results-Postoperative complications developed in 10% of dogs. Postoperative mortality rate was 7.1%. Predictive factors for postoperative death included high preoperative WBC count and postoperative complications. Twenty-one percent of dogs in which portal scintigraphy was performed 6 to 10 weeks after surgery had continued shunting. Predictive factors for persistent shunting included low preoperative plasma albumin concentration, high portal pressure after complete occlusion, and high portal pressure difference (postocclusion minus baseline). Clinical outcome in 108 dogs was classified as excellent (80%), good (14%), or poor (6%). Predictive factors for excellent long-term clinical outcome included high preoperative plasma albumin concentration, low preoperative leukocytosis, low portal pressure after complete occlusion, absence of postoperative seizures, and absence of continued shunting. CONCLUSIONS AND CLINICAL RELEVANCE: Use of an ARC for treatment for a single extrahepatic PSS resulted in low morbidity and mortality rates. Certain preoperative factors were associated with increased risk of postoperative death, continued portosystemic shunting, and long-term outcome.  相似文献   
68.
The use of artificial insemination (AI) with fresh semen has resulted in many benefits for the management of dog breeding, but there are disadvantages that can sometimes be overlooked. Furthermore, poorer quality semen arising as a result of cryopreservation necessitates uterine insemination, which raises the potential for surgical insemination. A number of significant ethical concerns have been raised by key stakeholders (such as The Kennel Club and the Royal College of Veterinary Surgeons) about AI per se , but particularly about the use of surgical insemination. This paper discusses the technological development of AI and explores a number of the ethical issues raised by its application to dog breeding. An Ethical Matrix method is used to map the potential ethical issues for key interest groups, namely dogs, breeders, owners, veterinarians and wider society. There are national variations in the way in which institutions have evaluated potential ethical impacts, and this is reflected in the different regulatory frameworks governing the use of AI in dogs. In order to facilitate decision-making and reduce some of the ethical risks associated with this technology, the veterinary research community could take several proactive steps including: (i) clarifying clinical decision-making processes, (ii) enhancing informed choice among clients and (iii) increasing the knowledge-base of potential impacts of AI.  相似文献   
69.
Sperm sexing is an emerging reproductive technology which has been successfully used to produce offspring of a pre‐determined sex in domestic and wildlife species but has yet to be applied to New World camelids. The aims of the present study were to (i) optimize the Hoescht 33342 (H33342) staining concentration for the flow cytometric separation of X and Y chromosome‐bearing alpaca (Vicugna pacos) sperm nuclei, (ii) separate alpaca sperm nuclei into high purity (>90%) populations bearing the X‐ and Y‐chromosome and (iii) determine the DNA difference between X‐ and Y‐bearing sperm in alpacas. Semen was collected from alpacas and sperm nuclei stained with H33342, incubated and analysed using a high‐speed cell sorter (SX‐MoFlo®). H33342 staining concentrations of 36, 54, 72 or 90 μm did not affect the proportion of correctly oriented sperm nuclei (43.3 ± 3.9, 46.4 ± 3.7, 44.5 ± 4.0 and 51.1 ± 2.5% respectively) nor the speed of sorting (1381 ± 160, 1386 ± 123, 1371 ± 133 and 1379 ± 127 sperm nuclei/s). Sort reanalysis determined high levels of purity for X‐ and Y‐enriched populations (96.6 ± 0.7% and 96.1 ± 1.1% respectively). The DNA difference, based on fluorescence intensity (determined by the SX‐MoFlo®), was 3.8 ± 0.06%. These data demonstrate for the first time that alpaca sperm nuclei can be separated into high purity populations and the potential for applying sperm sexing technology to New World camelids.  相似文献   
70.
Hydroxyzine is a first‐generation antihistamine and cetirizine, a second‐generation antihistamine and active metabolite of hydroxyzine. Hydroxyzine is commonly used in performance horses and as such its use in closely regulated; however, there are no published studies suitable for establishing appropriate regulatory recommendations. In the current study, 12 exercised Thoroughbred research horses received a single oral administration of 500 mg of hydroxyzine. Blood and urine samples were collected prior to and up to 96 hr postdrug administration and concentrations of hydroxyzine and cetirizine determined using liquid chromatography‐tandem mass spectrometry. A joint parent/metabolite population 2‐compartment pharmacokinetic model with first‐order absorption and elimination was utilized to describe the pharmacokinetics of both compounds. Serum hydroxyzine and cetirizine concentrations were above the limit of quantitation (0.1 ng/ml) of the assay at 96 hr (the last time point sampled). The terminal half‐life was 7.41 and 7.13 hr for hydroxyzine and cetirizine, respectively. Findings from this study suggest that a prolonged withdrawal time should be observed if this compound is used in performance administered to performance horses and is classified as prohibited substance by the applicable regulatory body.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号